# Nasdaq:HUMA news releases

Nasdaq:HUMA press releases distributed through HARO Newswire to the journalists who cover the beat.

- **Releases in the last 90 days:** 391
- **Web page:** https://www.helpareporter.com/news-releases/nasdaqhuma
- **RSS:** https://www.helpareporter.com/news-releases/nasdaqhuma/rss.xml

### [Humacyte Submits Supplemental Biologics License Application to FDA for the Acellular Tissue Engineered Vessel in Dialysis Access](https://www.helpareporter.com/news-releases/humacyte-submits-supplemental-biologics-license-application-to-fda-for)

November 19, 2026 · Humacyte · Nasdaq:HUMA

–sBLA submission seeks to add arteriovenous access for hemodialysis as second approved indication for the ATEV. –sBLA supported by results from three Phase 3 studies in hemodialysis access.
